TESARO (TSRO) – FDA
-
TESARO (TSRO) Announces Immuno-Oncology Data Presentations at SITC
-
TESARO (TSRO) Reports Updated Phase 1 GARNET Data of TSR-042 (anti-PD-1 antibody) in Patients with Recurrent or Advanced MSI-H
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TSRO Stock Lookup